91 related articles for article (PubMed ID: 7029282)
1. Monoclonal antibodies to T-cell subsets in renal-allograft recipients.
N Engl J Med; 1981 Dec; 305(24):1473-4. PubMed ID: 7029282
[No Abstract] [Full Text] [Related]
2. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.
Cosimi AB; Colvin RB; Burton RC; Rubin RH; Goldstein G; Kung PC; Hansen WP; Delmonico FL; Russell PS
N Engl J Med; 1981 Aug; 305(6):308-14. PubMed ID: 6454075
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to human T cell subsets: use for immunological monitoring and immunosuppression in renal transplantation.
Burton RC; Cosimi AB; Colvin RB; Rubin RH; Delmonico FL; Goldstein G; Russell PS
J Clin Immunol; 1982 Jul; 2(3 Suppl):142S-147S. PubMed ID: 6290526
[TBL] [Abstract][Full Text] [Related]
4. Immunological monitoring of renal allograft recipients using monoclonal antibodies to human T lymphocyte subpopulations.
Ellis TM; Berry CR; Mendez-Picon G; Goldman MH; Lower RR; Lee HM; Mohanakumar T
Transplantation; 1982 Mar; 33(3):317-9. PubMed ID: 6461117
[No Abstract] [Full Text] [Related]
5. Role of T-cell-subset monitoring in renal-allograft recipients.
Morris PJ; Carter NP; Cullen PR; Thompson JF; Wood RF
N Engl J Med; 1982 May; 306(18):1110-1. PubMed ID: 7040954
[No Abstract] [Full Text] [Related]
6. [In vivo use of OKT3 monoclonal antibodies in recipients of renal allografts].
Chatenoud L; Bach JF
Nephrologie; 1987; 8(3):95-8. PubMed ID: 3309702
[TBL] [Abstract][Full Text] [Related]
7. T cell-specific monoclonal antibodies abrogate the blood transfusion effect on kidney allograft survival in rhesus monkeys.
den Butter G; Jonker M; Nooij FJ; van Schilfgaarde R; van Es AA
Transplant Proc; 1987 Feb; 19(1 Pt 2):1461-3. PubMed ID: 3274355
[No Abstract] [Full Text] [Related]
8. Immunoexpression of perforin and granzyme B on infiltrating lymphocytes in human renal acute allograft rejection.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2003; 23(6):538-44. PubMed ID: 15002789
[TBL] [Abstract][Full Text] [Related]
9. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
[No Abstract] [Full Text] [Related]
10. Diagnostic and therapeutic applications of monoclonal antibodies to human T-cell subsets in renal transplant recipients.
Cosimi AB
Urol Clin North Am; 1983 May; 10(2):289-99. PubMed ID: 6344388
[No Abstract] [Full Text] [Related]
11. Treatment of acute cellular kidney allograft rejection with T10B9.1A-31A anti T-cell monoclonal antibody.
Waid TH; Lucas BA; Thompson JS; Brown S; Moore D; Amlot P; Janossy G
Transplant Proc; 1989 Feb; 21(1 Pt 2):1778-84. PubMed ID: 2652582
[No Abstract] [Full Text] [Related]
12. Therapeutic use of monoclonal antibodies in kidney transplantation.
Kreis H; Chkoff N; Vigeral P; Chatenoud L; Lacombe M; Campos H; Pruna A; Goldstein G; Bach JF; Crosnier J
Adv Nephrol Necker Hosp; 1985; 14():389-407. PubMed ID: 3919540
[No Abstract] [Full Text] [Related]
13. CD4 monoclonal antibodies in the preclinical dog renal allograft model.
Watson CJ; Davies HS; Metcalfe SM; Cobbold SP; Rebello PR; Collier DS; Waldmann H; Calne RY
Transplant Proc; 1993 Feb; 25(1 Pt 1):804-6. PubMed ID: 8438491
[No Abstract] [Full Text] [Related]
14. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process.
Reinke P; Kern F; Fietze E; Döcke WD; Ewert R; Emmrich F; Volk HD
Transplant Proc; 1995 Feb; 27(1):859-62. PubMed ID: 7879207
[No Abstract] [Full Text] [Related]
15. New insights into therapy with monoclonal antibodies in allograft transplantation.
Schena FP
Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
[No Abstract] [Full Text] [Related]
16. T11+/DR+ lymphocytes in renal allograft recipients with irreversible rejection.
Hayes JM; Valenzuela R; Novick AC; Steinmuller DR
Transplantation; 1988 Apr; 45(4):806-9. PubMed ID: 2895969
[No Abstract] [Full Text] [Related]
17. The effects of immunomodulation on peripheral T cell subsets.
Chatenoud L; Berrih S; Bene MC; Kreis H; Bach JF
J Clin Immunol; 1982 Jul; 2(3 Suppl):61S-66S. PubMed ID: 6290529
[TBL] [Abstract][Full Text] [Related]
18. T-cell subsets in a cyclosporin-A treated recipient of cadaveric kidney allograft as defined by theophylline sensitivity and monoclonal antibodies.
Shohat B; Shapira Z; Servadio C
Dev Biol Stand; 1984; 57():361-6. PubMed ID: 6396131
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies for kidney allograft rejection.
Med Lett Drugs Ther; 1986 Oct; 28(724):97-8. PubMed ID: 3531791
[No Abstract] [Full Text] [Related]
20. T-lymphocyte subsets in renal allograft recipients undergoing different immunosuppression protocols.
Sumpio BE; Dwyer JM; Flye MW
Curr Surg; 1986; 43(6):502-5. PubMed ID: 3542396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
